Two Sigma Advisers
USNA icon

Two Sigma Advisers’s Usana Health Sciences USNA Stock Holding History

Two Sigma Advisers’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-65,700
Closed -$1.29M – 2060
2025
Q4 		$1.29M Sell
65,700
-14,600
-18% -$303K ﹤0.01% 1357
2025
Q3 		$2.21M Buy
80,300
+66,200
+470% +$2.04M ﹤0.01% 1104
2025
Q2 		$430K Buy
+14,100
New +$400K ﹤0.01% 1815
2025
Q1 		– Sell
-7,000
Closed -$251K – 2592
2024
Q4 		$251K Buy
7,000
+200
+3% +$7.48K ﹤0.01% 2050
2024
Q3 		$258K Sell
6,800
-5,700
-46% -$234K ﹤0.01% 1974
2024
Q2 		$566K Sell
12,500
-21,600
-63% -$994K ﹤0.01% 1831
2024
Q1 		$1.65M Sell
34,100
-5,200
-13% -$255K ﹤0.01% 1323
2023
Q4 		$2.11M Sell
39,300
-4,800
-11% -$243K ﹤0.01% 1261
2023
Q3 		$2.58M Buy
44,100
+16,200
+58% +$1.01M 0.01% 1059
2023
Q2 		$1.76M Buy
27,900
+15,300
+121% +$974K ﹤0.01% 1265
2023
Q1 		$793K Buy
12,600
+5,600
+80% +$334K ﹤0.01% 1749
2022
Q4 		$372K Buy
+7,000
New +$379K ﹤0.01% 1997
2021
Q4 		– Sell
-41,122
Closed -$3.79M – 2814
2021
Q3 		$3.79M Sell
41,122
-17,400
-30% -$1.67M 0.01% 919
2021
Q2 		$5.99M Buy
58,522
+6,200
+12% +$622K 0.02% 782
2021
Q1 		$5.11M Sell
52,322
-13,100
-20% -$1.19M 0.01% 841
2020
Q4 		$5.04M Buy
65,422
+3,800
+6% +$294K 0.01% 808
2020
Q3 		$4.54M Sell
61,622
-2,456
-4% -$197K 0.01% 801
2020
Q2 		$4.71M Buy
64,078
+22,900
+56% +$1.8M 0.01% 825
2020
Q1 		$2.38M Buy
41,178
+7,500
+22% +$522K 0.01% 1025
2019
Q4 		$2.65M Sell
33,678
-32,200
-49% -$2.37M 0.01% 1098
2019
Q3 		$4.5M Sell
65,878
-137,500
-68% -$9.23M 0.01% 802
2019
Q2 		$16.2M Buy
203,378
+107,200
+111% +$8.5M 0.04% 456
2019
Q1 		$8.07M Buy
96,178
+18,100
+23% +$1.89M 0.02% 672
2018
Q4 		$9.19M Sell
78,078
-10,600
-12% -$1.23M 0.03% 591
2018
Q3 		$10.7M Sell
88,678
-3,400
-4% -$422K 0.03% 561
2018
Q2 		$10.6M Buy
92,078
+4,000
+5% +$438K 0.03% 571
2018
Q1 		$7.57M Sell
88,078
-6,263
-7% -$485K 0.02% 692
2017
Q4 		$6.99M Sell
94,341
-10,437
-10% -$698K 0.02% 728
2017
Q3 		$6.05M Buy
104,778
+15,013
+17% +$887K 0.02% 732
2017
Q2 		$5.75M Buy
89,765
+39,887
+80% +$2.46M 0.02% 700
2017
Q1 		$2.87M Buy
49,878
+29,600
+146% +$1.77M 0.01% 1083
2016
Q4 		$1.24M Sell
20,278
-1,600
-7% -$104K ﹤0.01% 1452
2016
Q3 		$1.51M Buy
21,878
+11,800
+117% +$778K 0.01% 1152
2016
Q2 		$561K Buy
10,078
+1,600
+19% +$96.5K ﹤0.01% 1468
2016
Q1 		$515K Sell
8,478
-6,800
-45% -$400K ﹤0.01% 1445
2015
Q4 		$976K Sell
15,278
-27,600
-64% -$1.79M 0.01% 1031
2015
Q3 		$2.9M Sell
42,878
-3,000
-7% -$212K 0.02% 624
2015
Q2 		$3.13M Sell
45,878
-5,600
-11% -$355K 0.02% 635
2015
Q1 		$2.86M Sell
51,478
-24,000
-32% -$1.23M 0.02% 648
2014
Q4 		$3.87M Buy
75,478
+52,400
+227% +$2.57M 0.03% 566
2014
Q3 		$850K Buy
23,078
+1,600
+7% +$57.7K 0.01% 1231
2014
Q2 		$839K Sell
21,478
-5,600
-21% -$208K 0.01% 1298
2014
Q1 		$1.02M Buy
27,078
+5,000
+23% +$175K 0.01% 1146
2013
Q4 		$835K Sell
22,078
-14,000
-39% -$536K 0.01% 1247
2013
Q3 		$1.57M Sell
36,078
-23,800
-40% -$955K 0.02% 746
2013
Q2 		$2.17M Buy
+59,878
New +$1.82M 0.03% 485

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's USNA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Usana Health Sciences (USNA) in Q1 2026, closing a stake of 65,700 shares — an estimated $1.29M sold.

Two Sigma Advisers first reported a position in USNA in Q2 2013 and held it in 46 quarters. The position peaked at $16.2M in Q2 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Usana Health Sciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 65,700 Usana Health Sciences shares in Q1 2026, an estimated $1.29M.
  • Two Sigma Advisers first reported a position in Usana Health Sciences in Q2 2013 and held it in 46 quarters.
  • Two Sigma Advisers's Usana Health Sciences position peaked at $16.2M in Q2 2019.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.